Number of the records: 1
Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
- 1.JANIKASHVILI, N., GÉRARD, C., THÉBAULT, M., BRÁZDOVÁ, Andrea, BOIBESSOT, C., CLADIÈRE, C., CIUDAD, M., GREIGERT, H., OUANDJI, S., GHESQUIÈRE, T., SAMSON, M., AUDIA, S., SAAS, P., BONNOTTE, B. Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect. OncoImmunology. 2021, 10(1), 1880046. ISSN 2162-4011. Available: doi: 10.1080/2162402X.2021.1880046.
Number of the records: 1